Papers/PMID:34180336
The role of lycopene for the amelioration of glycaemic status and peripheral antioxidant capacity among the Type II diabetes mellitus patients: a case-control study.
Annals of medicine2021The record
2 findings · 1 compound · 2 endpoints
What it reported
How to read these marksWhat moved
2 findings
lycopene — decreases glycated haemoglobin (HbA1c)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Contrarily, HbA1c and FPG levels decreased significantly with the higher lycopene intake.”
Quoted verbatim from The role of lycopene for the amelioration of glycaemic status and peripheral antioxidant capacity among the Type II diabetes mellitus patients: a case-control study.. - Study
- case-control
- Population
- Patients with type 2 diabetes mellitus within a case-control study; dietary lycopene by food frequency questionnaire; association with intake level
The role of lycopene for the amelioration of glycaemic status and peripheral antioxidant capacity among the Type II diabetes mellitus patients: a case-control study.2021PMID:34180336Permalink
lycopene — decreases fasting blood glucose
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Contrarily, HbA1c and FPG levels decreased significantly with the higher lycopene intake.”
Quoted verbatim from The role of lycopene for the amelioration of glycaemic status and peripheral antioxidant capacity among the Type II diabetes mellitus patients: a case-control study.. - Study
- case-control
- Population
- Patients with type 2 diabetes mellitus within a case-control study; dietary lycopene by food frequency questionnaire; association with intake level
The role of lycopene for the amelioration of glycaemic status and peripheral antioxidant capacity among the Type II diabetes mellitus patients: a case-control study.2021PMID:34180336Permalink